RESULTS	At month 24 , virological response rate [ hepatitis B virus ( HBV ) DNA < 60 IU/ml ] was higher in the adefovir-lamivudine combination group compared with entecavir group ( 56.7 % vs. 40 % , P = 0.025 ) , although biochemical and serological response rates were not significantly different .\